Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Board Changes

4 Dec 2015 07:00

RNS Number : 9729H
HydroDec Group plc
04 December 2015
 

4 December 2015

 

Hydrodec Group plc

("Hydrodec" or the "Company")

 

Board changes

 

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group, announces that Ian Smale, Chief Executive, will step down as Chief Executive of the Company by mutual agreement today. Since joining in 2012, Ian has led the Company's expanded footprint and been fundamental to the development of the Company's strategy. The Board is grateful to him for his leadership and commitment and wishes him well for the future.

 

The Board is pleased to announce the appointment of the Company's current Chief Financial Officer, Chris Ellis, as Acting Chief Executive with immediate effect. Chris' appointment is for an initial term of up to 6 months and Chris will, in the near term, undertake the roles of both Acting Chief Executive and Chief Financial Officer. Chris is a qualified chartered accountant and has more than 20 years' board level finance and management experience of running a range of large, complex international businesses as well as small and medium sized ventures, including a significant period within GE Capital. The Board believes no immediate replacement for the role of Chief Financial Officer will be required as Chris will continue to work with the Board and his finance team to ensure processes are in place to ensure his ongoing financial role is appropriately supported. The Company intends to commence an appropriate process to make an executive appointment to the Board in due course as necessary.

 

The Company also announces today that Caroline Brown will assume the role of Senior Independent Director with effect from today, having joined the Company as an Independent Non-Executive Director and Chair of the Audit Committee on 23 September 2015. Caroline will support Chris in ensuring the financial function is appropriately managed and monitored.

 

Chairman, Lord Moynihan stated: "The ongoing ramp-up to full operations in Canton coupled with the recently announced long-term funding are a platform for a strong focus on operational delivery and the next phase in the Company's development. The Board is grateful for Ian's leadership through the recent difficulties which we believe are now behind us.

2016 will be an important year for Hydrodec. With our Canton plant in production, the focus is on production and sale of transformer oil into the U.S. market as this represents the key generator of cash in the Company portfolio. We remain confident that the rebuilt and expanded plant has a unique market proposition and is well placed in 2016 to leverage the production of the highest quality transformer oil produced in the US. Our objective remains to grow a profitable Company and deliver value for shareholders through integrated used oil re-refining solutions based on market-leading proprietary technology.

The whole Board is focused on execution, delivering improved operational performance and efficiencies and driving the Company to profitability and this is reinforced by the appointment of Chris Ellis as Acting Chief Executive."

For further information please contact:

 

Hydrodec Group plc

 

020 3300 1643

 

Lord Moynihan, Chairman

Chris Ellis, Acting Chief Executive

James Hodges, General Counsel and Company Secretary

 

 

 

Canaccord Genuity (Nominated Adviser and Broker)

 

020 7523 8000

 

Guy Marks

Henry Fitzgerald-O'Connor

 

 

 

Vigo Communications (PR adviser to Hydrodec)

 

020 7016 9570

Patrick d'Ancona

Chris McMahon

 

 

 

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US and Young, New South Wales, Australia. In 2013, Hydrodec acquired the business and assets of OSS Group, the UK's largest collector, consolidator and processor of used lubricant oil and seller of processed fuel oil, with a national network of oil storage and transfer stations. Used oil is converted into processed fuel oil at OSS's plant at Stourport and principally sold on to the UK quarry and power industry. In April 2015, Hydrodec further acquired the business and assets of Eco Oil, a leading UK waste oil collector and supplier of recycled industrial fuel oil into the power and road stone industries. It is also one of four significant providers of waste management services to the marine industry in the UK, specifically oily-water slops or marine pollutant (MARPOL). In line with our stated intention to develop a base oil re-refinery in the UK, we have an exclusive licence agreement with California-based Chemical Engineering Partners (CEP) to develop the CEP wiped-film evaporation and hydrogenation technology in the UK as well as the basic engineering for a 75 million litre per annum capacity base oil re-refinery.

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAUOUKRVRAURAA
Date   Source Headline
2nd Nov 20127:00 amRNSConvertible Unsecured Loan Stock
31st Oct 20123:37 pmRNSDirector's dealing in securities
31st Oct 20127:00 amRNSDirector's dealing in securities
25th Oct 20127:00 amRNSDirector's dealing in securities
24th Oct 20127:00 amRNSAppointment of Chairman
12th Sep 201210:50 amRNSNotification of Interest
6th Sep 20127:00 amRNSInterim Results
16th Aug 201211:13 amRNSNotification of Interim Results
9th Aug 20122:07 pmRNSDirectorate Change
6th Aug 201210:35 amRNSJoint marketing agreement
3rd Jul 20127:00 amRNSDirector's dealing
27th Jun 20122:37 pmRNSUS approves treatment of PCB-contaminated oil
25th Jun 201212:00 pmRNSResult of AGM
25th Jun 20127:00 amRNSAGM Statement
15th Jun 20127:00 amRNSContract Win
8th Jun 20121:03 pmRNSAppointment of Chief Financial Officer
22nd May 20124:17 pmRNSNotification of interest
4th May 201212:36 pmRNSDirector's Dealing
25th Apr 20124:15 pmRNSEPA issues draft approval
19th Apr 20127:00 amRNSFinal Results
3rd Apr 20127:00 amRNSNotice of Results
13th Mar 201211:53 amRNSChange of Registered Office
17th Feb 20123:44 pmRNSDirector Dealing
1st Feb 20122:25 pmRNSDirector's Dealing
30th Jan 20121:12 pmRNSDirectorate Change
25th Jan 20129:14 amRNSDirector's dealing
18th Jan 20125:35 pmRNSDirector's Dealing
17th Jan 20123:24 pmRNSDirector's dealing
16th Jan 20127:00 amRNSTrading Update
7th Dec 20117:00 amRNSAppointments
28th Nov 20113:30 pmRNSNotification of Interest
28th Nov 201112:15 pmRNSNotification of Interest
28th Nov 201111:43 amRNSTotal Voting Rights
21st Nov 201110:46 amRNSResult of General Meeting
3rd Nov 20113:15 pmRNSPosting of Circular
2nd Nov 20117:00 amRNSAppointment of CEO and Placing
31st Oct 20114:17 pmRNSRe press speculation
26th Sep 201111:26 amRNSDirector's dealing - Replacement
26th Sep 20117:00 amRNSDirector's dealing
21st Sep 20117:00 amRNSInterim Results
26th Aug 20113:00 pmRNSDirector change in information
12th Jul 20117:00 amRNSDirector's dealing
11th Jul 201111:28 amRNSSigning of first operating joint venture in Japan
23rd Jun 20117:00 amRNSDirectorate Change
9th Jun 201111:51 amRNSResult of AGM
9th Jun 20117:00 amRNSAGM Statement
8th Jun 20118:38 amRNSNotification of Interest
25th May 201110:01 amRNS£2 million debt financing to fund growth
17th May 201112:33 pmRNSAnnual Report & Notice of AGM
26th Apr 20115:17 pmRNSNotification of Interest

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.